[Effect of the block of beta-adrenergic receptors in tachycardia due to thyreotoxicosis].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D005260:Female; D006042:Goiter / Q000150:complications; D006111:Graves Disease / Q000150:complications; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy*; D013964:Thyroid Neoplasms / Q000150:complications
D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D011433:Propranolol
Effetto del blocco dei recettori beta-adrenergici nella tachicardia da tireotossicosi.